Invention Grant
US09095596B2 Treatment of neurodegenerative diseases, causation of memory enhancement, and assay for screening compounds for such
有权
神经变性疾病的治疗,记忆增强的病因,以及用于筛选化合物的测定
- Patent Title: Treatment of neurodegenerative diseases, causation of memory enhancement, and assay for screening compounds for such
- Patent Title (中): 神经变性疾病的治疗,记忆增强的病因,以及用于筛选化合物的测定
-
Application No.: US13501934Application Date: 2010-10-14
-
Publication No.: US09095596B2Publication Date: 2015-08-04
- Inventor: Maurizio Grimaldi , Judith Varady Hobrath , Subramaniam Ananthan , Joseph A. Maddry
- Applicant: Maurizio Grimaldi , Judith Varady Hobrath , Subramaniam Ananthan , Joseph A. Maddry
- Applicant Address: US AL Birmingham
- Assignee: Southern Research Institute
- Current Assignee: Southern Research Institute
- Current Assignee Address: US AL Birmingham
- Agency: Novak Druce Connolly Bove + Quigg LLP
- International Application: PCT/US2010/052624 WO 20101014
- International Announcement: WO2011/047129 WO 20110421
- Main IPC: A61K31/675
- IPC: A61K31/675 ; A61K31/427 ; A61K31/4402 ; C07D417/02 ; C07D417/14 ; C07D277/38 ; C07D277/20 ; C07D213/72

Abstract:
Methods for enhancing memory and/or learning and prevent neurodegeneration by administration of certain heterocyclic and aromatic compounds are described. The methods are particularly useful for treating patients suffering from a neurodegenerative disease such as (without limitation) Alzheimer's, Parkinsons's, Lou Gehrig's (ALS) disease or memory or learning impairment. A neuronal human cell-based assay that assess NF-kB gene up-regulation using a luciferase reporter is also provided that screens for compounds useful in methods for enhancing memory or learning.
Public/Granted literature
Information query